Sunhawk Vision Biotech, Inc. (TPEX:7759)

Sunhawk Vision Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	255.22	111.4	175.07
Short-Term Investments	200	91.4	53.5
Cash & Short-Term Investments	455.22	202.8	228.57
Cash Growth	149.07%	-11.28%	-
Other Receivables	8.26	5.36	2.33
Receivables	8.26	5.36	2.33
Prepaid Expenses	26.89	16.09	10.44
Total Current Assets	490.76	224.24	241.34
Property, Plant & Equipment	11.13	13.37	8.98
Other Intangible Assets	70.13	70.15	70.19
Other Long-Term Assets	1.02	1.02	0.33
Total Assets	573.04	308.78	320.85
Accrued Expenses	17.12	2.94	7.61
Current Portion of Leases	3.8	3.76	0.76
Other Current Liabilities	0.14	0.18	0.04
Total Current Liabilities	21.06	6.87	8.42
Long-Term Leases	3.82	5.72	2.87
Total Liabilities	24.87	12.6	11.29
Common Stock	700.68	632.18	211
Additional Paid-In Capital	338.3	59	-
Retained Earnings	-489.76	-394.8	-93.75
Comprehensive Income & Other	-1.07	-0.21	192.31
Shareholders' Equity	548.16	296.18	309.56
Total Liabilities & Equity	573.04	308.78	320.85
Total Debt	7.61	9.48	3.63
Net Cash (Debt)	447.61	193.31	224.93
Net Cash Growth	161.09%	-14.06%	-
Net Cash Per Share	6.76	3.10	3.64
Filing Date Shares Outstanding	70.07	63.22	61.72
Total Common Shares Outstanding	70.07	63.22	61.72
Working Capital	469.7	217.37	232.93
Book Value Per Share	7.82	4.69	5.02
Tangible Book Value	478.03	226.03	239.38
Tangible Book Value Per Share	6.82	3.58	3.88
Machinery	-	4.99	5.57
Leasehold Improvements	-	1.15	0.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.